• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND SARS-COV-2 IGG II QUANT REAGENT KIT; REAGENT, CORONAVIRUS SEROLOGICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND SARS-COV-2 IGG II QUANT REAGENT KIT; REAGENT, CORONAVIRUS SEROLOGICAL Back to Search Results
Catalog Number 06S60-23
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.This report is being filed on an international product, list number 6s60-23 (sars-cov-2 igg ii quant ) and has a similar product distributed in the us, list number 6s60-20/-30 (advisedx sars-cov-2 igg ii: eua#: (b)(4)).
 
Event Description
The customer observed a false negative sars-cov-2 igg ii quant result for a 40 year old male physician who was pcr positive on (b)(6) 2022.The following data was provided (reference range: results <50.0 au/ml is negative): (b)(6) 2022, sid (b)(6) initial result was 7.6 au/ml no impact to patient management was reported.
 
Manufacturer Narrative
The complaint investigation for a false negative sars-cov-2 igg ii quant result included a search for similar complaints, and the review of complaint text, trending data, labelling, and device history records.Additionally, in-house performance testing for reagent lot 36532fn00 was completed.Return testing was not performed as returns were not available.Device history record review on lot 36532fn00 did not show any potential non-conformances, or deviations associated with the customer¿s observation.Labelling was reviewed and found to adequately address the issue under review.In-house performance testing for reagent lot 36532fn00 was completed using a retained sample of the complaint lot.All specifications were met indicating the lot is performing acceptably.The reason for the negative result is unclear.Per the limitations of the procedure section of the package insert, immunocompromised patients who have covid-19 may have a delayed antibody response and produce levels of antibody which may not be detected as positive by the assay.However, in this case it was reported that the patient had no underlying conditions that may have contributed to a poor immune response.Per product labeling, higher titer antibody responses have been observed in patients with more severe illness as compared with mildly symptomatic or asymptomatic individuals.Based on the investigation, no systemic issue or deficiency of the sars-cov-2 igg ii quant reagent lot 36532fn00 was identified.This report is being filed on an international product, list number 6s60-23 (sars-cov-2 igg ii quant ) and has a similar product distributed in the us, list number 6s60-20/-30 (advisedx sars-cov-2 igg ii: eua # 203119).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SARS-COV-2 IGG II QUANT REAGENT KIT
Type of Device
REAGENT, CORONAVIRUS SEROLOGICAL
Manufacturer (Section D)
ABBOTT IRELAND
finisklin business park
sligo F91VY 44
EI  F91VY44
Manufacturer (Section G)
ABBOTT IRELAND
finisklin business park
sligo F91VY 44
EI   F91VY44
Manufacturer Contact
siobhan wright
lisnamuck
post market surveillance
longford N39 E-932
EI   N39 E932
433331157
MDR Report Key15451155
MDR Text Key300652595
Report Number3008344661-2022-00112
Device Sequence Number1
Product Code QKO
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 12/09/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/19/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/18/2022
Device Catalogue Number06S60-23
Device Lot Number36532FN00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/16/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/19/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARC I2K PROC MOD, 03M74-01, ISR63712; ARC I2K PROC MOD, 03M74-01, ISR63712
-
-